Alembic Pharma Q1 Results: Net profit rises 12% YoY to Rs 135 crore 0 08.08.2024 17:55 Economictimes.indiatimes.com Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 14% YoY to Rs 239 crore, while the EBITDA margins contracted 540 basis points on y-o-y basis to 15.3% Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
